Chemotherapy versus alectinib for the treatment of crizotinib-pretreated ALK-positive patients with non small cell lung cancer A protocol for systematic review and meta-analysis

Gao, T; Li, CX; He, XP; Zhang, T

Zhang, T (通讯作者),XianYang Cent Hosp, Dept Chest Surg, Xianyang 712000, Shaanxi, Peoples R China.

MEDICINE, 2022; 101 (11):

Abstract

Background: There are no evidence-based data in the literature to demonstrate that alectinib shows a clinically relevant advantage over chemotherapy i......

Full Text Link